- Home
- GNK vs GHRS Comparison
GNK vs GHRS Comparison
Compare GNK & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | GHRS |
|---|---|---|
| Founded | 2004 | 2018 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 967.7M | 947.2M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GNK | GHRS |
|---|---|---|
| Price | $24.50 | $21.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $19.00 | ★ $41.38 |
| AVG Volume (30 Days) | ★ 270.0K | 255.2K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $342,054,000.00 | N/A |
| Revenue This Year | $21.15 | N/A |
| Revenue Next Year | $1.41 | N/A |
| P/E Ratio | $117.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.66 | $10.67 |
| 52 Week High | $27.25 | $24.66 |
Technical Indicators
Market Signals| Indicator | GNK | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 49.71 | 57.31 |
| Support Level | $22.40 | $12.41 |
| Resistance Level | N/A | $22.88 |
| Average True Range (ATR) | 0.90 | 1.32 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 22.69 | 54.94 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.